Alert: China Issues New Policy for Drug and Medical Device Approvals

Published date18 October 2017
Law FirmCooley LLP
AuthorChristina Zhang
Subject MatterMedical Devices,China,Clinical Trials,Prescription Drugs,China FDA,Pharmaceutical Industry

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT